Explore Puerto Rico’s Bioscience Leadership at BIO 2026

Invest Puerto Rico will participate in the BIO International Convention 2026, the world’s leading event for the biotechnology and life sciences industry.

Join us June 22–25, 2026, at the San Diego Convention Center, and visit Booth 3935 in Hall E to discover why Puerto Rico remains one of the most established and strategic life sciences jurisdictions operating under the U.S. regulatory framework.

For companies evaluating U.S. expansion, advanced manufacturing, R&D investment, or supply chain diversification, Puerto Rico offers scale, compliance, and long-term operational strength.

Meet with Invest Puerto Rico at Booth 3935

Stop by Booth 3935 to connect with the Invest Puerto Rico team and explore how Puerto Rico supports:

• Biopharmaceutical manufacturing expansion
• Advanced therapy and biologics production
• Fill & finish and sterile injectables
• CDMO partnerships
• Clinical trial activity
• Life sciences R&D operations

We welcome biotech innovators, pharmaceutical manufacturers, investors, CDMOs, and site selection consultants to schedule meetings in advance for dedicated time with our team.

Why Puerto Rico for Biosciences?

Puerto Rico is home to one of the most mature pharmaceutical manufacturing ecosystems in the United States, supported by decades of global industry leadership.

Manufacturing Depth & Technical Capabilities

• Extensive biologics, sterile injectables, and small molecule manufacturing
• Robust fill & finish capabilities (vials, syringes, combination products)
• Advanced lyophilization capabilities
• Comprehensive bio product testing and quality systems
• Strong CDMO presence

Research & Innovation Infrastructure

• Molecular Sciences Research Center (MSRC)
• Forward Center for Innovation & Commercialization
• Puerto Rico Consortium for Clinical Investigation (PRCCI)
• University and research institution partnerships

Strategic U.S. Advantages

• 4% corporate tax rate under Puerto Rico’s incentive framework
• Up to 50% R&D tax credits
• Full U.S. FDA regulatory alignment
• Strong intellectual property protections
• Competitive operating costs compared to many mainland U.S. markets
• Established global logistics and distribution infrastructure

Puerto Rico offers a resilient, compliant, and scalable platform for companies seeking to strengthen their U.S. life sciences footprint.